Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (PureCircle Limited)

16 Apr 2020 15:08

RNS Number : 9303J
Ingredion Incorporated
16 April 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Ingredion SRSS Holdings Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

-

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PureCircle Limited

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

9 April 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

None

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

9 April 2020

Contact name:

Tiffany Willis

Telephone number:

+1 708 551 2592

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEKZGMDFVVGGZM
Date   Source Headline
6th Feb 20187:00 amRNSNotice of Results
1st Feb 20187:00 amRNSTotal Voting Rights
2nd Jan 20187:00 amRNSBlock Listing Six Monthly Return
1st Dec 20179:50 amRNSResult of AGM
18th Oct 20177:00 amRNSNotice of AGM
29th Sep 20173:39 pmRNSDirector/PDMR Shareholding
29th Sep 20173:39 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:46 pmRNSDirector/PDMR Shareholding
19th Sep 20177:00 amRNSFinal Results
31st Aug 20177:00 amRNSInclusion in FTSE All-share index
15th Aug 20177:00 amRNSNotice of Results
1st Aug 20177:00 amRNSTotal Voting Rights
17th Jul 20178:37 amRNSDirector/PDMR Shareholding
13th Jul 20178:31 amRNSAppointment of Director - Correction
11th Jul 20177:00 amRNSAdditional Listing
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20177:00 amRNSBlock Listing Six Monthly Return
22nd Jun 20177:00 amRNSAppointment of Director
22nd Jun 20177:00 amRNSBoard Committee Changes
2nd Jun 20178:06 amRNSHolding(s) in Company
30th May 201711:05 amRNSDirector Declaration
17th May 20177:00 amRNSIP and patent protection developments
2nd May 20177:00 amRNSTrading Update
2nd May 20177:00 amRNSTotal Voting Rights
26th Apr 20179:45 amRNSCompany Secretary Name Change
25th Apr 20171:17 pmRNSDirector/PDMR Shareholding
15th Mar 20179:58 amRNSDirector/PDMR Shareholding
9th Mar 201711:19 amRNSDirector/PDMR Shareholding
7th Mar 20177:00 amRNSHalf Yearly Report
2nd Mar 201710:00 amRNSPureCircle Completes Stevia Plant Expansion
31st Jan 20177:00 amRNSTotal Voting Rights
30th Jan 20177:00 amRNSRemoval of Restriction on Imports into the U.S.
26th Jan 20174:40 pmRNSSecond Price Monitoring Extn
26th Jan 20174:35 pmRNSPrice Monitoring Extension
20th Jan 201711:34 amRNSDirector/PDMR Shareholding
10th Jan 20177:00 amRNSRelease of U.S. Shipments
5th Jan 20177:00 amRNSTrading Update
3rd Jan 20174:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20174:35 pmRNSPrice Monitoring Extension
30th Dec 20167:00 amRNSBlock listing Interim Review
1st Dec 20169:36 amRNSResult of AGM
14th Nov 20167:00 amRNSDirector/PDMR Shareholding
14th Nov 20167:00 amRNSDirector/PDMR Shareholding
2nd Nov 20168:31 amRNSNotice of AGM and Annual Report: Amendment
2nd Nov 20167:00 amRNSNotice of AGM and Annual Report
1st Nov 20167:00 amRNSAppointment of Chief Operating Officer
31st Oct 20167:00 amRNSTotal Voting Rights
11th Oct 20164:48 pmRNSDirector/PDMR Shareholding
30th Sep 20167:00 amRNSTotal Voting Rights
28th Sep 20164:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.